Ignite Creation Date:
2024-05-05 @ 10:00 AM
Last Modification Date:
2024-10-26 @ 9:03 AM
Study NCT ID:
NCT00003641
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-07-03
First Post:
1999-11-01
Brief Title:
High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
Sponsor:
ECOG-ACRIN Cancer Research Group
Organization:
Eastern Cooperative Oncology Group
Key Dates - Follows AllAPIJSON File Order
Start Date:
1999-03-25
Start Date Type:
ACTUAL
Primary Completion Date:
2015-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-10
Completion Date Type:
ESTIMATED
First Submit Date:
1999-11-01
First Submit QC Date:
January 26 2003
Study First Post Date:
2003-01-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2016-05-04
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-29
Last Update Post Date:
2024-07-03
Last Update Post Date Type:
ACTUAL